Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
Clinical trial NCT03742245 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03742245
- Sponsor
- The Methodist Hospital Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-11
- Primary completion
- 2025-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.